Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Who owns pembrolizumab?Fosaprepitant dimeglumine?Veletri pharmaceutical company trial?Afinitor expiry date?When will there be a generic nexletol?
See the DrugPatentWatch profile for Santyl
Santyl is a brand of collagenase (collagenase clostridium histolyticum) used as a topical medication to help remove nonviable (dead) tissue from chronic wounds, such as pressure ulcers and other types of wounds that need debridement [1].
Because Santyl is a collagenase enzyme, it works by enzymatically breaking down collagen in nonviable tissue. That helps support wound debridement (the process of removing dead tissue) so the wound can heal [1].
No. Santyl’s main role is enzymatic debridement. It is not classified as an antibiotic in the way that wound antibiotics are [1].
Santyl is one option within wound debridement approaches. Other wound debridement methods include surgical/physical debridement and other chemical or enzymatic agents, but Santyl specifically is the collagenase enzymatic category [1].
If you’re searching for the drug class for prescribing or insurance purposes, the most useful term is the generic name: collagenase. That is how most formularies categorize it [1].
Other Questions About Santyl :